Third Rock Ventures IV, L.P. is 10% Owner at Tango Therapeutics, Inc. (TNGX). They have made 5 open-market trades across 1 company since 2024, most recently 2025-02-03.
CIK 0001688327
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 60% | 100% |
| Avg Move | -6.5% | -13.3% | -44.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNGX | SELL | 2024-08-30 | 2024-09-04 | $11.60 | $2.0M | -11.3% | -35.6% | -66.0% |
| TNGX | SELL | 2024-08-27 | 2024-08-29 | $11.55 | $289K | -13.0% | -30.9% | -63.4% |
| TNGX | SELL | 2024-07-24 | 2024-07-26 | $9.85 | $3.9M | -10.2% | +22.9% | -35.2% |
| TNGX | SELL | 2024-07-18 | 2024-07-22 | $9.81 | $3.8M | -2.8% | +7.0% | -26.4% |
| TNGX | SELL | 2024-02-20 | 2024-02-21 | $12.00 | $1.9M | +4.9% | -29.7% | -32.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.